Outside of VA, we know they were targeting FDA submission in...

Outside of VA, we know they were targeting FDA submission in FY2024 for the CT:VQ (perfusion) which represents a huge opportunity and for the XV scanner - so these shouldn't be too far away. Imbio also have their own FDA and EMA submissions and approval outcomes due this year too, and have advanced discussions as of end of Feb 2024 with a new potential partner.

Outcomes of discussions for DOD, U.S. based academic medical centres or other impatient radiology clinics might also come to fruition too, as well as further private insurer reimbursement arrangements, among many other things going that we might not even know about!